221 related articles for article (PubMed ID: 12857557)
1. Thrombophilic mutations are a main risk factor for placental abruption.
Facchinetti F; Marozio L; Grandone E; Pizzi C; Volpe A; Benedetto C
Haematologica; 2003 Jul; 88(7):785-8. PubMed ID: 12857557
[TBL] [Abstract][Full Text] [Related]
2. Factor V Leiden in pregnancies complicated by placental abruption.
Procházka M; Happach C; Marsál K; Dahlbäck B; Lindqvist PG
BJOG; 2003 May; 110(5):462-6. PubMed ID: 12742330
[TBL] [Abstract][Full Text] [Related]
3. Frequency of selected thrombophilias in women with placental abruption.
Procházka M; Lubuský M; Slavík L; Hrachovec P; Zielina P; Kudela M; Lindqvist PG
Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):297-301. PubMed ID: 17627684
[TBL] [Abstract][Full Text] [Related]
4. [Impact of inherited thrombophilia on the development of some pregnancy complications].
Koleva R; Dimitrova V; Chernev T; Savov A; Karag'ozova Zh; Mazneŭkova V; Kremenski I
Akush Ginekol (Sofiia); 2005; 44(5):18-26. PubMed ID: 16313049
[TBL] [Abstract][Full Text] [Related]
5. Increased frequency of genetic thrombophilia in women with complications of pregnancy.
Kupferminc MJ; Eldor A; Steinman N; Many A; Bar-Am A; Jaffa A; Fait G; Lessing JB
N Engl J Med; 1999 Jan; 340(1):9-13. PubMed ID: 9878639
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.
Finan RR; Tamim H; Ameen G; Sharida HE; Rashid M; Almawi WY
Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960
[TBL] [Abstract][Full Text] [Related]
7. Inherited thrombophilias and adverse pregnancy outcomes: a case-control study in an Australian population.
Said JM; Higgins JR; Moses EK; Walker SP; Monagle PT; Brennecke SP
Acta Obstet Gynecol Scand; 2012 Feb; 91(2):250-5. PubMed ID: 21985600
[TBL] [Abstract][Full Text] [Related]
8. Lower birth-weight in neonates of mothers carrying factor V G1691A and factor II A(20210) mutations.
Grandone E; Margaglione M; Colaizzo D; Pavone G; Paladini D; Martinelli P; Di Minno G
Haematologica; 2002 Feb; 87(2):177-81. PubMed ID: 11836168
[TBL] [Abstract][Full Text] [Related]
9. Familial thrombophilia and the occurrence of fetal growth restriction.
Martinelli P; Grandone E; Colaizzo D; Paladini D; Sciannamé N; Margaglione M; Di Minno G
Haematologica; 2001 Apr; 86(4):428-31. PubMed ID: 11325651
[TBL] [Abstract][Full Text] [Related]
10. Genetic thrombophilic mutations among couples with recurrent miscarriage.
Jivraj S; Rai R; Underwood J; Regan L
Hum Reprod; 2006 May; 21(5):1161-5. PubMed ID: 16431900
[TBL] [Abstract][Full Text] [Related]
11. [Genetic thrombophilic defects (Factor V Leiden, prothrombin G20210A, MTHFR C677T) in women with recurrent fetal loss].
Kovacheva K; Ivanov P; Konova E; Simeonova M; Komsa-Penkova R
Akush Ginekol (Sofiia); 2007; 46(7):10-6. PubMed ID: 18333414
[TBL] [Abstract][Full Text] [Related]
12. Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage.
Coulam CB; Jeyendran RS; Fishel LA; Roussev R
Am J Reprod Immunol; 2006 May; 55(5):360-8. PubMed ID: 16635210
[TBL] [Abstract][Full Text] [Related]
13. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey.
Altintas A; Pasa S; Akdeniz N; Cil T; Yurt M; Ayyildiz O; Batun S; Isi H
Ann Hematol; 2007 Oct; 86(10):727-31. PubMed ID: 17572893
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
[TBL] [Abstract][Full Text] [Related]
15. Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome.
Agorastos T; Karavida A; Lambropoulos A; Constantinidis T; Tzitzimikas S; Chrisafi S; Saravelos H; Vavilis D; Kotsis A; Bontis J
J Matern Fetal Neonatal Med; 2002 Oct; 12(4):267-73. PubMed ID: 12572596
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
[TBL] [Abstract][Full Text] [Related]
17. Thrombophilic mutations in pre-eclampsia and pregnancy-induced hypertension.
Omar SZ; Qvist R; Khaing SL; Muniandy S; Bhalla S
J Obstet Gynaecol Res; 2008 Apr; 34(2):174-8. PubMed ID: 18412778
[TBL] [Abstract][Full Text] [Related]
18. Inherited and acquired thrombophilia: pregnancy outcome and treatment.
De Santis M; Cavaliere AF; Straface G; Di Gianantonio E; Caruso A
Reprod Toxicol; 2006 Aug; 22(2):227-33. PubMed ID: 16797917
[TBL] [Abstract][Full Text] [Related]
19. Adverse pregnancy outcomes are associated with multiple maternal thrombophilic factors.
Tranquilli AL; Giannubilo SR; Dell'Uomo B; Grandone E
Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):144-7. PubMed ID: 15541848
[TBL] [Abstract][Full Text] [Related]
20. Inherited risk of thrombosis of the fetus and intrauterine fetal death.
Dekker JW; Lind J; Bloemenkamp KW; Quint WG; Kuijpers JC; van Doorn LJ; de Groot CJ
Eur J Obstet Gynecol Reprod Biol; 2004 Nov; 117(1):45-8. PubMed ID: 15474243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
